EWTX - Edgewise Therapeutics GAAP EPS of -$0.31 beats by $0.05 February, 23 2023 08:49 AM Edgewise Therapeutics Inc. Edgewise Therapeutics press release ( NASDAQ: EWTX ): Q4 GAAP EPS of -$0.31 beats by $0.05 . Cash, cash equivalents and marketable securities were $352 million as of December 31, 2022. For further details see: Edgewise Therapeutics GAAP EPS of -$0.31 beats by $0.05